| Term | Count | % | | TREATMENT FAILURE | 5894 | 7.43% |
| DRUG INEFFECTIVE | 3043 | 3.84% |
| EYE IRRITATION | 2291 | 2.89% |
| FATIGUE | 2043 | 2.58% |
| INTRAOCULAR PRESSURE INCREASED | 1810 | 2.28% |
| HEADACHE | 1612 | 2.03% |
| EYE PAIN | 1567 | 1.98% |
| DYSPNOEA | 1541 | 1.94% |
| DEATH | 1519 | 1.91% |
| VISION BLURRED | 1509 | 1.90% |
| DIZZINESS | 1503 | 1.89% |
| DIARRHOEA | 1458 | 1.84% |
| NAUSEA | 1434 | 1.81% |
| OFF LABEL USE | 1429 | 1.80% |
| CATARACT | 1350 | 1.70% |
| OCULAR HYPERAEMIA | 1343 | 1.69% |
| FALL | 1338 | 1.69% |
| GLAUCOMA | 1320 | 1.66% |
| PAIN | 1188 | 1.50% |
| ASTHENIA | 1174 | 1.48% |
| HYPERSENSITIVITY | 1141 | 1.44% |
| MALAISE | 969 | 1.22% |
| VISUAL IMPAIRMENT | 954 | 1.20% |
| RASH | 951 | 1.20% |
| PNEUMONIA | 923 | 1.16% |
| PRURITUS | 883 | 1.11% |
| WEIGHT DECREASED | 873 | 1.10% |
| CONDITION AGGRAVATED | 865 | 1.09% |
| PAIN IN EXTREMITY | 848 | 1.07% |
| ARTHRALGIA | 842 | 1.06% |
| COUGH | 821 | 1.03% |
| VOMITING | 805 | 1.01% |
| HYPERTENSION | 803 | 1.01% |
| EYE PRURITUS | 763 | 0.96% |
| DRUG HYPERSENSITIVITY | 742 | 0.94% |
| VISUAL ACUITY REDUCED | 727 | 0.92% |
| CONSTIPATION | 683 | 0.86% |
| DRY EYE | 676 | 0.85% |
| INSOMNIA | 654 | 0.82% |
| EYE DISORDER | 647 | 0.82% |
| PYREXIA | 647 | 0.82% |
| CONFUSIONAL STATE | 641 | 0.81% |
| DEPRESSION | 600 | 0.76% |
| DECREASED APPETITE | 592 | 0.75% |
| BACK PAIN | 588 | 0.74% |
| PRODUCT DOSE OMISSION ISSUE | 582 | 0.73% |
| PRODUCT QUALITY ISSUE | 576 | 0.73% |
| ACUTE KIDNEY INJURY | 568 | 0.72% |
| CEREBROVASCULAR ACCIDENT | 566 | 0.71% |
| URINARY TRACT INFECTION | 545 | 0.69% |
| SOMNOLENCE | 538 | 0.68% |
| ANAEMIA | 531 | 0.67% |
| GAIT DISTURBANCE | 530 | 0.67% |
| INCORRECT DOSE ADMINISTERED | 515 | 0.65% |
| FEELING ABNORMAL | 500 | 0.63% |
| CHEST PAIN | 499 | 0.63% |
| BLOOD PRESSURE INCREASED | 496 | 0.63% |
| HYPOTENSION | 493 | 0.62% |
| ANXIETY | 491 | 0.62% |
| ERYTHEMA | 486 | 0.61% |
| PALPITATIONS | 474 | 0.60% |
| LACRIMATION INCREASED | 470 | 0.59% |
| COVID-19 | 459 | 0.58% |
| BLINDNESS | 458 | 0.58% |
| ABDOMINAL DISCOMFORT | 446 | 0.56% |
| MYALGIA | 446 | 0.56% |
| DRUG INTOLERANCE | 431 | 0.54% |
| ATRIAL FIBRILLATION | 430 | 0.54% |
| RENAL FAILURE | 423 | 0.53% |
| PERIPHERAL SWELLING | 420 | 0.53% |
| MUSCLE SPASMS | 419 | 0.53% |
| NASOPHARYNGITIS | 418 | 0.53% |
| TREMOR | 417 | 0.53% |
| HAEMOGLOBIN DECREASED | 416 | 0.52% |
| PRODUCT USE ISSUE | 415 | 0.52% |
| OEDEMA PERIPHERAL | 410 | 0.52% |
| ARTHRITIS | 402 | 0.51% |
| PRODUCT USE IN UNAPPROVED INDICATION | 397 | 0.50% |
| ABDOMINAL PAIN | 387 | 0.49% |
| ABDOMINAL PAIN UPPER | 381 | 0.48% |
| ALOPECIA | 381 | 0.48% |
| BRONCHITIS | 381 | 0.48% |
| DEHYDRATION | 376 | 0.47% |
| MUSCULAR WEAKNESS | 369 | 0.47% |
| WEIGHT INCREASED | 366 | 0.46% |
| EYE SWELLING | 357 | 0.45% |
| MYOCARDIAL INFARCTION | 355 | 0.45% |
| SYNCOPE | 350 | 0.44% |
| INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION | 348 | 0.44% |
| MEMORY IMPAIRMENT | 345 | 0.43% |
| FOREIGN BODY SENSATION IN EYES | 344 | 0.43% |
| PARAESTHESIA | 335 | 0.42% |
| CARDIAC FAILURE CONGESTIVE | 331 | 0.42% |
| DYSGEUSIA | 329 | 0.41% |
| HYPOAESTHESIA | 327 | 0.41% |
| BALANCE DISORDER | 326 | 0.41% |
| BLOOD GLUCOSE INCREASED | 326 | 0.41% |
| ASTHMA | 318 | 0.40% |
| DRUG INTERACTION | 318 | 0.40% |
| VERTIGO | 318 | 0.40% |
| Total | 79339 | |